Trends is free while in Beta

Discover Trends in Pharma

We surface rapidly growing trends in Pharma before they take off.

Wolverine Peptide

27,100 vol/mo
9999%+
(5y)
762%
(1y)
10%
(3mo)

Wolverine peptide refers to a regenerative peptide stack commonly combining BPC 157 and TB 500 (Thymosin Beta 4 fragment) used in researc...

Peptide Stack

2,400 vol/mo
9620%
(5y)
629%
(1y)
-21%
(3mo)

Peptide Stack refers to the practice of combining multiple bioactive peptides to enhance recovery, performance, or healing outcomes. It s...

KPV Peptide

40,500 vol/mo
8719%
(5y)
541%
(1y)
1%
(3mo)

Retatrutide

301,000 vol/mo
6920%
(5y)
449%
(1y)
-23%
(3mo)

Retatrutide is a therapeutic candidate, a once weekly triple agonist targeting GLP 1, GIP, and glucagon receptors, being developed by Eli...

3247%
(5y)
328%
(1y)
-48%
(3mo)

Glucagon Like Peptide 1 (GLP 1) refers to a class of incretin hormones and corresponding receptor agonist drugs used to treat type 2 diab...

GLP1

823,000 vol/mo
2356%
(5y)
202%
(1y)
42%
(3mo)

Tesamorelin

135,000 vol/mo
1442%
(5y)
379%
(1y)
-20%
(3mo)

Tesamorelin is a synthetic growth hormone releasing factor used to treat HIV associated lipodystrophy; its relevance as a trending topic ...

MOTS-C

60,500 vol/mo
1441%
(5y)
779%
(1y)
41%
(3mo)

Truemed

27,100 vol/mo
1315%
(5y)
92%
(1y)
3%
(3mo)

Truemed is a wellness/health platform focused on HSA/FSA eligible products and lifestyle interventions, led by notable proponents and att...

GLP-1

823,000 vol/mo
1082%
(5y)
127%
(1y)
-24%
(3mo)

GLP 1 refers to glucagon like peptide 1 hormones and the associated class of incretin based therapies. The trend centers on their use for...

Medsender

4,400 vol/mo
950%
(5y)
63%
(1y)
-20%
(3mo)

CJC-1295

60,500 vol/mo
908%
(5y)
420%
(1y)
-65%
(3mo)

TB-500

49,500 vol/mo
847%
(5y)
370%
(1y)
-65%
(3mo)

Radioligand

590 vol/mo
761%
(5y)
202%
(1y)
-67%
(3mo)

Radioligand refers to radiolabeled molecules used in nuclear medicine for both diagnostic imaging and targeted radiotherapy, forming a co...

Epitalon

5,400 vol/mo
572%
(5y)
288%
(1y)
-34%
(3mo)

BPC-157

301,000 vol/mo
567%
(5y)
215%
(1y)
-59%
(3mo)

BPC 157 is a synthetic pentadecapeptide that has circulated in wellness and clinical upgrade communities for tissue repair and anti infla...

388%
(5y)
323%
(1y)
-83%
(3mo)
380%
(5y)
265%
(1y)
42%
(3mo)

TB500

49,500 vol/mo
379%
(5y)
103%
(1y)
-22%
(3mo)

TB 500, a synthetic peptide corresponding to thymosin beta 4, is discussed in online communities for purported tissue repair and recovery...

Ipamorelin

33,100 vol/mo
277%
(5y)
229%
(1y)
-40%
(3mo)

Ideaya

1,900 vol/mo
230%
(5y)
112%
(1y)
-41%
(3mo)

Ideaya Therapeutics is a biotechnology company focused on precision oncology by exploiting synthetic lethality in cancer. The topic repre...

AccuCold

590 vol/mo
212%
(5y)
129%
(1y)
-71%
(3mo)

Accucold is a medical and life science refrigeration brand division under Felix Storch, Inc. that focuses on vaccine storage, clinical re...

Enteric Coating

6,600 vol/mo
196%
(5y)
187%
(1y)
9999%+
(3mo)

Enteric coating is a pharmaceutical technology used to protect orally administered drugs from the acidic environment of the stomach, ensu...

CJC 1295

60,500 vol/mo
194%
(5y)
159%
(1y)
-18%
(3mo)

CJC 1295 is a synthetic peptide used to stimulate growth hormone release, widely discussed in bodybuilding and anti aging communities. It...

Senolytic

3,600 vol/mo
194%
(5y)
52%
(1y)
-63%
(3mo)

Senolytics are therapies designed to selectively eliminate senescent cells to mitigate aging related diseases and improve healthspan. The...

Ceramide

22,200 vol/mo
183%
(5y)
233%
(1y)
-79%
(3mo)

Silexan

3,600 vol/mo
176%
(5y)
117%
(1y)
-26%
(3mo)

Silexan is a standardized lavender oil extract used primarily as an herbal anxiolytic, supported by clinical studies and available as a p...

ImmunityBio

12,100 vol/mo
172%
(5y)
163%
(1y)
-46%
(3mo)

ImmunityBio is a biotechnology company focused on cancer immunotherapy and infectious disease vaccines, developing IL 15 based therapies ...

Drug Discovery

1,300 vol/mo
168%
(5y)
158%
(1y)
-66%
(3mo)

SGLT2 Inhibitor

40,500 vol/mo
163%
(5y)
201%
(1y)
-57%
(3mo)

SGLT2 inhibitors are a class of prescription medications originally developed for type 2 diabetes that have gained attention for broader ...